OncoPep Completes $11 Million Series D Financing to Continue

/PRNewswire/ -- OncoPep, Inc., a developer of transformative immunotherapeutics, announced $11 million in Series D funding. The Series D was led by Tera...

Related Keywords

Boston , Massachusetts , United States , Waltham , Cambridge , Cambridgeshire , United Kingdom , Kendall Square , Christopher Bahl , Michael Krepps , Kukje Pharma , Dennis Klinman , National Cancer Institute , Inflammation Program Immune Modulation Section , Sx Company , Dartmouth University , University Of Pennsylvania , Oncopep Inc , University Of Maine , Institute For Protein Innovation , Tera Science , Massachusetts Based Oncopep , Boston Kendall , Scientific Advisory , Senior Investigator , Inflammation Program , Immune Modulation , Protein Design , Protein Innovation , Oncopep , Nc ,